Top Abstract Purchase Related
Home
>
Node
>
Subnode

GABAergic mechanism of cerebrovasculareffect of mexidol

Gnezdilova, A.V.; Gan'shina, T.S.; Mirzoian, R.S.

Eksperimental'naia i Klinicheskaia Farmakologiia 73(10): 11-13

2010

ISSN/ISBN: 0869-2092
PMID: 21254506
Document Number: 644176
Experiments on rats showed that mexidol significantly increases local cerebral blood flow in animals under conditions of global transient brain ischemia, whereas in intact rats this drug initially causes a decrease in the blood flow, followed by its recovery. Mechanism of the cerebrovascular effect of mexidol is determined by its action on GABA receptors of cerebral vessels, which confirmed the fact that the cerebrovascular effect of mexidol is absent in the presence of bicuculline.

Document emailed within 1 workday
Secure & encrypted payments

Kraĭneva, V.A. 2006: The experimental study of peculiarities and mechanism of neuroprotective action of mexidol in hemorrhagic stroke Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova Suppl 17: 71-76
Kosenko, V.G.; Karagezian, E.A.; Luneva, L.V.; Smolenko, L.F. 2006: The use of mexidol in psychiatric practice Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 106(6): 38-41
Ivanov, I.V.; Chudnykh, S.M.; Mozgalin, A.G. 2002: Effectiveness of mexidol in acute pancreatitis Klinicheskaia Meditsina 80(9): 44-46
Vamvakidès, A. 1998: Spongiform encephalopathies: a second chance for GABAergic agonists Annales Pharmaceutiques Francaises 56(1): 26-30
Mal'gina, N.V. 2006: Mexidol in combined treatment of acute pancreatitis Khirurgiia 10: 42-50
Matthieu, J.M.; Honegger, P. 1996: Propofol is toxic for immature GABAergic neurons Revue Medicale de la Suisse Romande 116(12): 971-973
Kuznetsova, E.B.; Sholomov, I.I.; Gerasimov, S.V.; Salina, E.A. 2014: Efficiency of mexidol in patients with endocrine polyneuropathy Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 114(4): 97-99
Shchul'kin, A.V.; Iakusheva, E.N.; Chernykh, I.V. 2014: The distribution of mexidol in the rat's brain and its subcellular fractions Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 114(8): 70-73
Solís-Añez, E.; Delgado-Luengo, W.; Hernández, M.ía.L. 2007: Autism, chromosome 15 and the GAbaergic dysfunction hypothesis Investigacion Clinica 48(4): 529-541
Deshevoĭ, I.B.; Moroz, B.B.; Cukoian, G.V.; Voronina, T.A.; Lebedev, V.G.; Lyrshchikova, A.V. 2007: Acute radiation sickness in experiment. Efficacy of mexidol Patologicheskaia Fiziologiia i Eksperimental'naia Terapiia 3: 22-24
Racagni, G.; Apud, J.A.; Masotto, C.; Rovescalli, A.C.; Cocchi, D.; Locatelli, V.; Müller, E.E. 1986: The hypothalamo-pituitary GABAergic regulation of prolactin release in the rat Advances in Biochemical Psychopharmacology 42: 103-117
Natriashvili, G.D.; Kapanadze, N.B.; Natriashvili, S.G. 2005: Efficiency of mexidol during perinatal encephalopathy in early age children Georgian Medical News 123: 35-39
Kotliarov, A.A.; Smirnov, L.D.; Smirnova, L.E.; Kurkina, N.V.; Balykova, L.A.; Kariakina, T.N. 2002: Combined administration of mexidol and anti-arrhythmia agents Eksperimental'naia i Klinicheskaia Farmakologiia 65(5): 31-34
Iasnetsov, V.V.; Voronina, T.A. 2009: Effect of semax and mexidol on brain ischemia models in rats Eksperimental'naia i Klinicheskaia Farmakologiia 72(1): 68-70
Sariev, A.K.; Zherdev, V.P.; Litvin, A.A.; Kolyvanov, G.B.; Neznamov, G.G.; Petrova, T.N.; Davydova, I.A. 1999: The kinetics of the urinary excretion of mexidol and its glucuronate conjugate in patients Eksperimental'naia i Klinicheskaia Farmakologiia 62(5): 42-46
Barros, H.M.; Tannhauser, S.L.; Tannhauser, M.A.; Tannhauser, M. 1994: The effects of GABAergic drugs on grooming behaviour in the open field Pharmacology and Toxicology 74(6): 339-344
Ribak, C.E. 1992: Local circuitry of GABAergic basket cells in the dentate gyrus Epilepsy Research. Suppl 7: 29-47
Reggio, A.; Giammona, G.; Patti, F.; Condorelli, D.F.; Rampello, L.; Nicoletti, F.; Canonico, P.L.; Di Giorgio, R.M. 1981: Effect of 5 days reserpine treatment on the cerebellar GABAergic system Acta Neurologica 3(5): 687-689
Golikov, A.P.; Golikov, P.P.; Davydov, B.V.; Riabinin, V.A.; Luk'ianov, M.M.; Kalinin, A.N.; Klychnikova, E.V.; Promanenkov, V.K. 2002: Effect of mexidol on oxidative stress in cerebral variant of hypertensive crisis Kardiologiia 42(3): 25-29
Likhacheva, E.B.; Sholomov, I.I. 2006: Clinical and immunological assessment of efficacy of mexidol in the treatment of lumbosacral radiculopathy Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 106(10): 52-57